Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Dapsone

George Kurien  1 , Radia T. Jamil  2 , Charles V. Preuss  3
In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Dapsone

George Kurien et al.
Free Books & Documents

Excerpt

Dapsone is an antibiotic medication used in multidrug regimens and approved by the United States Food and Drug Administration (FDA) for treating leprosy and dermatitis herpetiformis. Initially investigated as an antibiotic agent in 1937, dapsone was first utilized for leprosy treatment in 1945. The drug is also prescribed for a range of conditions, including both dermatological and non-dermatological ailments. Dapsone is currently available in both oral and topical formulations.

PubMed Disclaimer

Conflict of interest statement

Disclosure: George Kurien declares no relevant financial relationships with ineligible companies.

Disclosure: Radia Jamil declares no relevant financial relationships with ineligible companies.

Disclosure: Charles Preuss declares no relevant financial relationships with ineligible companies.

References

    1. Zhu YI, Stiller MJ. Dapsone and sulfones in dermatology: overview and update. J Am Acad Dermatol. 2001 Sep;45(3):420-34. - PubMed
    1. Liang SE, Hoffmann R, Peterson E, Soter NA. Use of Dapsone in the Treatment of Chronic Idiopathic and Autoimmune Urticaria. JAMA Dermatol. 2019 Jan 01;155(1):90-95. - PMC - PubMed
    1. Ramos FS, Ferreira FR, Rabay FMO, Lira MLA. Neutrophilic dermatosis of the dorsal hands: response to dapsone monotherapy. An Bras Dermatol. 2018 Sep-Oct;93(5):730-732. - PMC - PubMed
    1. Kumar B. Re: Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009-2015. Clin Microbiol Infect. 2019 May;25(5):644-645. - PubMed
    1. Din RS, Tsiaras WG, Li DG, Mostaghimi A. Efficacy of Systemic Dapsone Treatment for Pyoderma Gangrenosum: A Retrospective Review. J Drugs Dermatol. 2018 Oct 01;17(10):1058-1060. - PubMed

Publication types

LinkOut - more resources